Our Platform
Kelonia’s revolutionary iGPS® technology makes CAR T therapies available to patients when and where they need them.
A wholly owned subsidiary of Eli Lilly and Company
A wholly owned subsidiary of Eli Lilly and Company
Kelonia’s revolutionary iGPS® technology makes CAR T therapies available to patients when and where they need them.